Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only : systematic review and economic evaluation /: systematic review and economic evaluation. (April 2016)

• Record Type: Book
• Further Information: Note: Matt Stevenson [and eleven others].
• Authors: Stevenson, M (Matt)
• Other Names: National Institute for Health Research (Great Britain); NIHR Journals Library, publisher.
• Publisher Details: Southampton : NIHR Journals Library
• Publication Date: 2016
• Extent: 1 online resource (lvii, 610 pages), illustrations (colour)
• Subjects: 616.72270610724; Rheumatoid arthritis -- Chemotherapy -- Evaluation; Rheumatoid arthritis -- Chemotherapy -- Cost effectiveness; Clinical trials
• Languages: English
• Notes: Note: Includes bibliographical references.
• Access Rights: Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
• Access Usage: Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.